IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities.

IFN-tau (IFN-tau) constitutes a new class of type I IFN which is not virus-inducible, unlike IFN-alpha and IFN-beta, but is constitutively produced by the trophectoderm of the ruminant conceptus during a very short period in early pregnancy. It plays a pivotal role in the mechanisms of maternal recognition of pregnancy in ruminants and it displays high antiviral and antiproliferative activities across species with a prominent lack of cytotoxicity at high concentrations in vitro in cell culture and possibly in vivo. It exhibits high antiretroviral activity against HIV and exhibits immunosuppressive activity in a multiple sclerosis model and reduces embryo and fetal mortality by stimulation of IL-10 production. In this review all the biochemical and para-hormonal properties of this novel IFN-tau are described in detail: structural characteristics of proteins and genes, trophoblast expression, regulation of its expression, structure of its gene promoter, its absence in human species and in non-ruminant animals, the evolution of the IFN-tau genes, its structure-function relationships with its three-dimensional structure, structural localization of biological activities, its lack of cytotoxicity and its receptor. Surprisingly, for an IFN, IFN-tau is also a pregnancy-embryonic signal with paracrine antiluteolytic activity. In order to maintain luteal progesterone secretion, IFN-tau inhibits PGF-2alpha pulsatile secretion and oxytocin uterine receptivity in early pregnancy. It is believed to suppress pulsatile release of endometrial PGF-2alpha by preventing oxytocin and estrogen receptor expression. Additionally, it directly regulates prostaglandin metabolism and possibly the PGE:PGF-2alpha ratio.

Production of monoclonal antibodies against Clostridium difficile cytotoxin using immunosorbent binding bioassay procedure.

In the following study, a novel screening approach was used to develop monoclonal antibodies specific for toxin B of Clostridium difficile. The approach, which consisted of an immunosorbent binding bioassay (ISBBA), is based on antigen immunocapture by monoclonal antibodies and detection of biological activity. Our results showed ISBBA, which uses unpurified antigen, to be more sensitive than the neutralization assay and ELISA for the detection of toxin B antibody.

A single intrauterine infusion of sustained recombinant ovine interferon-tau extends corpus luteum lifespan in cyclic ewes.

Delivery carriers were developed to permit sustained release of recombinant ovine tau-interferon (roIFN-tau) to increase corpus luteum (CL) lifespan in cyclic ewes following a single intrauterine administration on Day 10 post estrus. A single infusion with 1.7 mg roIFN-tau covalently bound to carboxymethyl biogel agarose (carbodiimide coupling) significantly increased the interestrus interval (P < 0.01) in treated (n = 4) versus control animals (n = 6), whereas liposomally encapsulated roIFN-tau administered to experimental ewes (n = 8) versus control ewes (n = 6) was less effective (P < 0.05). RoIFN-tau covalently bound to trisacryl (glutaraldehyde coupling) was also effective in cyclic ewes (n = 6), but covalent binding to Eupergit C through oxirane bonds yielded ineffective preparations. Ewes that were given 1.7 mg soluble roIFN-tau (n = 8) displayed slight extension of the CL lifespan compared with ewes that were given 1.7 mg soluble BSA (n = 6), but this extension lacked significance in the Mann-Whitney U-test (P > 0.05). These results are consistent with previous data from experiments performed with daily intrauterine infusion of soluble, native or recombinant oIFN-tau. In addition, because CL maintenance requires only a single administration, these methods are efficient and simple to use since they avoid animal catheterization and allow for reduced injection frequency. Moreover, they may permit the use of smaller amounts of IFN. It is concluded that the use of oIFN-tau sustained in some delivery systems may allow for the development of an experimental sheep pseudopregnancy model.

Production of an hybridoma library to recombinant porcine alpha I interferon: a very sensitive assay (ISBBA) allows the detection of a large number of clones.

The preparation of a panel of hybridoma cell lines secreting monoclonal antibodies (MAbs) specific for Recombinant Porcine Alpha I Interferon is reported. Of these MAbs, 28 were subcloned and 21 secreted their antibody during several months. They were partially characterized for their ability to bind and neutralize Alpha Interferons (IFNs-alpha) from different animal species. All the clones bound Recombinant Porcine IFN-alpha 1, 8 bound Human leukocyte IFN, and one bound recombinant Human IFN-alpha 2b, but not IFN-alpha 2a. Two screening procedures were used for the detection of specific MAbs: neutralization assay and immunosorbent binding bioassay. This last method appears to be simple and very sensitive since it permits to detect 100 pg/ml MAb. In addition it can detect weakly, as well as strongly neutralizing antibodies. Probable mechanisms involved in this assay, and possible applications of this method for IFNs-alpha subtyping are discussed.

Comparative IFN-tau secretion after hatching by bovine blastocysts derived ex vivo and completely produced in vitro.

The interferon-tau (IFN-tau) secretion levels after hatching by bovine blastocysts derived from in vitro maturated oocytes (Group A) and from in vivo (Group B) were investigated considering embryo quality. Only very homogeneous blastocysts of excellent or good quality were considered from day 7 of culture (Group A) and day 7 after artificial insemination with frozen-thawed from the same bull used for in vitro fertilization (Group B). All embryos were individually cultured into a 50 microl droplet of synthetic oviduct fluid medium with 10% fetal calf serum. After 24-h culture both Group A (n=44) and B (n=40) secreted <54 pm IFN-tau. After 48-, 72-, 96- and 120-h culture, Group A daily secreted 143 +/- 24 pm IFN-tau (n=19) vs 85 +/- 12 pm IFN-tau (n=21) for Group B (p < 0.01), 491 +/- 128 pm IFN-tau (n=29) vs 216 +/- 37 pm IFN-tau (n=23) (NS), 499 +/- 135 pm IFN-tau (n=26) vs 353 +/- 93 pm IFN-tau (n=21) (NS), 559 +/- 136 pm IFN-tau (n=22) vs 333 +/- 75 pm IFN-tau (n=20) (NS), respectively. Taken all together during 5 days, Group A produced per embryo 1690 +/- 290 pm IFN-tau (n=22) vs 982 +/- 182 pm IFN-tau (n=20) for Group B (p < 0.05). For all culture time there were sizable percentages of embryos that did not produce concentrations of IFN-tau above a certain cut-off level, and as such were not used to compute the means. In respect of the embryo quality whatever the groups after days 7-12 of culture, IFN-tau secretions were 1815 +/- 453 pm (n=10) for the embryos of excellent quality vs 1356 +/- 200 pm (n=28) for those of good quality (NS) and 360 +/- 188 pm (n=4) (p < 0.05) for embryos of fair quality. A positive relationship between IFN-tau production and in vitro development of quality I embryos was observed, whatever the embryos origins and, the embryos completely produced in vitro secreted more IFN-tau than the embryos produced in vivo.

Immunosorbent binding bioassay: a solid phase biological immunoassay for the titration of antisera to alpha interferons.

An Immuno Sorbent Binding Bio-Assay (ISBBA) for the detection and the titration of antisera to the highly biologically active proteins, alpha interferons, is described. This method is similar to a classical solid phase immunoassay, except for the last step which uses the biological activity of the captured antigen. With specific serum antibodies the bound antigen prevents further virus induced cell lysis. On the contrary, with negative serum or preserum the antigen is washed out and virus induced cell lysis occurs, therefore no labelling is required. ISBBA exhibits three main differences when compared to the reference method i.e. the neutralization assay (NA): i) ISBBA is 10 to 1000 fold more sensitive than NA; ii) in contrast to NA, ISBBA is based on the production of an antiviral effect; iii) ISBBA makes it possible to use unpurified antigen. The applications of ISBBA to subtypes study in natural alpha interferon samples are discussed.